New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

IDNAvsPBEETF Comparison

ETF 1
IDNA

iShares Genomics Immunology and Healthcare ETF

This fund is part of
BioTech & Genomics
-0.87%
Full IDNA fund page
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.87%
Full PBE fund page

iShares Genomics Immunology and Healthcare ETF (IDNA) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.58% for PBE. IDNA is up 10.27% year-to-date (YTD) with +$6M in YTD flows. PBE performs worse with -7.11% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of IDNA and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IDNA vs PBE performance and flow charts

Performance

-50510%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

-4 M-2 M0 M2 M4 M6 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
IDNA
PBE
+0.52%-5.55%
+10.05%-4.87%
+10.27%-7.11%
+33.25%+17.56%
+29.09%+26.51%
-35.97%+3.80%
Flows
IDNA
PBE
+$6M-$3M
+$6M+$969K
+$6M+$135K
+$2M-$32M
-$21M-$56M
+$479K-$39M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IDNA
PBE
+23.81%+19.01%
+25.77%+22.33%
+24.07%+20.20%
+28.18%+22.79%
Max drawdown
IDNA
PBE
-7.09%-11.05%
-18.64%-16.18%
-30.61%-22.21%
-68.19%-34.74%
Max drawdown duration
IDNA
PBE
11d64d
127d107d
279d324d
1635d1540d
Trading data

Create an account to view trading data

Join for free
IDNA
PBE
Last sale
3/12/2026 at 1:30 PM
$28.91
$76.18
Previous close
03/12/2026
$29.96
$78.26
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IDNA
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
IDNA
PBE
Last price
$28.91
$76.18
1D performance
-3.50%
-2.66%
AuM$150.13 M$240.98 M
E/R0.47%0.58%
Characteristics
IDNA
PBE
Management strategyPassivePassive
ProvideriSharesInvesco
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma IndexDynamic Biotech & Genome Intellidex Index
N° of holdings4230
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 11, 2019June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

IDNA
USA
62.28%
France
8.3%
Other
29.42%
PBE
USA
94.25%
Other
5.75%

Sectors

IDNA
Health Care
93.2%
Other
6.8%
PBE
Health Care
96.95%
Other
3.05%
Advertisement

Diversification

IDNA

Total weight of top 15 holdings out of 15

62.44%
PBE

Total weight of top 15 holdings out of 15

61.48%

Top 15 holdings

Data as of January 31, 2026
IDNA
MODERNA INC
6.16%
BAYER AG
4.93%
REVOLUTION MEDICINES INC
4.49%
BIONTECH SE ADR
4.42%
TAKEDA PHARMACEUTICAL
4.32%
ROCHE
4.26%
IPSEN PROMESSES
4.18%
MERCK & CO INC
3.96%
GSK PLC
3.86%
VERTEX PHARMACEUTICALS
3.80%
REGENERON PHARMACEUTICALS
3.80%
GENMAB
3.80%
INCYTE
3.59%
EXELIXIS
3.47%
SANOFI SA
3.38%
PBE
ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
BIOGEN INC
4.76%
INCYTE
4.70%
ALNYLAM PHARMACEUTICALS
4.05%
AMICUS THERAPEUTICS
3.83%
DYNAVAX TECHNOLOGIES
3.60%
NL0015002SN0
3.05%
ACADIA PHARMACEUTICALS
2.98%
MANNKIND
2.89%
BIO-TECHNE CORP
2.83%
EXELIXIS
2.74%
Frequently asked questions about IDNA and PBE

How have the IDNA and PBE ETFs performed in 2026?

As of March 12, 2026, IDNA is up 10.27% year-to-date (YTD), while PBE has lost -7.11%. That puts IDNA better performer ahead so far this year.

Which ETF is attracting more investor money: IDNA or PBE?

Year-to-date, the IDNA ETF saw +$6M in flows, compared to +$135K for PBE.

Which ETF is more volatile: IDNA or PBE?

Over the past year, IDNA had a volatility of 25.77%, while PBE experienced 22.33%.

Which ETF is bigger: IDNA or PBE?

As of March 12, 2026, IDNA holds $150.13 M in assets under management (AUM), while PBE manages $240.98 M.

What sectors do the IDNA and PBE ETFs invest in?

IDNA leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the IDNA ETF and PBE ETF?

IDNA top holdings include MODERNA INC, BAYER AG and REVOLUTION MEDICINES INC. PBE holds in its top three: ILLUMINA, GILEAD SCIENCES and AMGEN-T.

Which ETF is more diversified: IDNA or PBE?

IDNA holds 51 securities with 62.44% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.48%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.